コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 esponsible for type I, type II, and type III tyrosinemia.
2 ish worms as a model for the study of type I tyrosinemia.
3 cer-prone metabolic liver disease hereditary tyrosinemia.
4 umarylacetoacetate hydrolase and manifesting tyrosinemia.
5 on in the Fah(-/-) mouse model of hereditary tyrosinemia.
6 mouse model of the human disease hereditary tyrosinemia.
7 ccinylacetone (SA), a marker for hepatorenal tyrosinemia.
8 lohexanedione (NTBC) is used to treat type I tyrosinemia, a rare but fatal defect in tyrosine catabol
9 approved for use in the treatment of type I tyrosinemia and as such has an extensive history of use
10 trategy to a mouse model of human hereditary tyrosinemia and show that the treatment generated fumary
15 wed it to become a curative agent for type I tyrosinemia (T1T) and to enter clinical trials for alkap
16 ification of two metabolic diseases (PKU and tyrosinemia) through blood analysis with minimal sample
22 hich is FDA approved for treating hereditary tyrosinemia type 1, elevates plasma tyrosine levels, and
26 the human metabolic liver disease hereditary tyrosinemia type I and a stringent in vivo model for hep
28 se model of the metabolic disease hereditary tyrosinemia type I was used to test whether targeted AAV
29 poson system in the treatment of hemophilia, tyrosinemia type I, junctional epidermolysis bullosa and
30 ls in the FAH(-/-) mouse, an animal model of tyrosinemia type I, rescued the mouse and restored the b
32 atients with the inborn errors of metabolism tyrosinemia type II, argininosuccinic aciduria, homocyst
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。